March 7-8, 2025 – Zennova Pharmaceuticals (Chengdu) Co., Ltd. (hereinafter referred to as "Zennova ") successfully passed its on-site GMP quality inspection for the Pharmaceutical Production License organized by the Sichuan Medical Products Administration (hereinafter "Sichuan MPA"). The successful completion of this official inspection signifies that Zennova's pharmaceutical quality management system, infrastructure facilities, and compliance capabilities have met the regulatory standards of China NMPA.  This achievement establishes a solid foundation for the company's expansion in both domestic and international markets. During the inspection process, the company demonstrated advanced production equipment, standardized operational procedures, and well-controlled quality systems, fully reflecting the professional standards of an international pharmaceutical enterprise.